- Home
- BETR vs SRZN Comparison
BETR vs SRZN Comparison
Compare BETR & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BETR | SRZN |
|---|---|---|
| Founded | 2014 | 2015 |
| Country | United States | United States |
| Employees | N/A | 59 |
| Industry | Finance: Consumer Services | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 275.0M | 271.6M |
| IPO Year | 2021 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BETR | SRZN |
|---|---|---|
| Price | $13.06 | $18.90 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $40.00 | $38.00 |
| AVG Volume (30 Days) | ★ 659.9K | 185.3K |
| Earning Date | 05-07-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.88 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $164,872,000.00 | $3,477,000.00 |
| Revenue This Year | $55.02 | $75.35 |
| Revenue Next Year | $65.66 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 51.97 | N/A |
| 52 Week Low | $11.11 | $11.30 |
| 52 Week High | $94.06 | $35.00 |
Technical Indicators
Market Signals| Indicator | BETR | SRZN |
|---|---|---|
| Relative Strength Index (RSI) | 41.99 | 31.85 |
| Support Level | $11.55 | $17.44 |
| Resistance Level | $15.30 | $24.13 |
| Average True Range (ATR) | 1.28 | 1.45 |
| MACD | 0.45 | -0.42 |
| Stochastic Oscillator | 50.17 | 19.29 |
Price Performance
Historical ComparisonAbout BETR Better Home & Finance Holding Company
Better Home & Finance Holding Co is a technology-enabled homeownership company that provides mortgage, home equity, and related services through a digital platform. The company operates through two reportable segments: Home Finance, which focuses on residential mortgage origination, including purchase, refinance, and home equity products, generating revenue mainly from loan sales; and Banking, which, through its U.K. subsidiary Birmingham Bank, offers a range of financial products and services to consumers and small businesses. It generates the majority of its revenue from the Home Finance segment.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).